Albuminuria Screening among Egyptian Patients With Cardiovascular Diseases, regardless of their diabetic condition

Authors

• Amira Fawzy Soliman, Lecturer Biochemistry, National Heart Institute, EGYPTFollow
• Khaled Shelbaya, Cardiology, National Heart Institute
• Wael Abdelatief Mohamed Elhakeem, Critical Care, National Heart Institute
• Osama Louis, Cardiology department, National Heart Institute
• Basheer Hafez, Cardiology, National Heart Institute
• Wael Ali, Cardiology, National Heart Institute
• Tarek M.Abdelaziz Elkholy, Cardiology, National Heart Institute
• Baher Emil Ibrahim, Clinical and Chemical Pathology, National heart institute
• Mahmoud M Abdou, Cardiology, National Heart Institute
• Bassem Zarif, Cardiology department, Consultant cardiologist, National Heart Institute, EGYPT

Abstract

Even in the absence of overt kidney disease, albuminuria is increasingly recognized as a marker of systemic endothelial dysfunction and heightened cardiovascular risk. This prospective cohort study aimed to evaluate whether baseline urinary albumin-tocreatinine ratio (UACR) predicts subsequent incident cardiovascular outcomes among Egyptian adults with cardiovascular disease, regardless of diabetic status.

Article Type

Original Study

Subject Area

Cardiology

IRB Number

IHC00061

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.

Recommended Citation

Soliman, Amira Fawzy; Shelbaya, Khaled; Elhakeem, Wael Abdelatief Mohamed; Louis, Osama; Hafez, Basheer; Ali, Wael; Elkholy, Tarek M.Abdelaziz; Ibrahim, Baher Emil; Abdou, Mahmoud M; and Zarif, Bassem (2026) "Albuminuria Screening among Egyptian Patients With Cardiovascular Diseases, regardless of their diabetic condition," Journal of Medicine in Scientific Research: Vol. 9: Iss. 2, Article 12.
DOI: https://doi.org/10.59299/2537-0928.1518